This website is intended for UK healthcare professionals only. Not a UK healthcare professional? Click here.
CLEAR Outcomes: Cardiovascular outcomes for bempedoic acid
Discover more about the CLEAR Outcomes trial results: Cardiovascular outcomes for bempedoic acid
Prof Derek Connolly, Prof Kausik Ray & Prof Terry McCormack
Date: 05/02/2025
18 mins
Speaker bios
Professor Derek Connolly
Consultant Cardiologist and Director of R&D at Birmingham City Hospital
Derek is a Consultant Cardiologist at Birmingham City Hospital, Birmingham UK and holds honorary academic positions at both the University of Birmingham Institute of cardiovascular sciences and at Aston University medical School. Derek trained in Cambridge, London, Edinburgh and San Diego where he was a Carnegie Scholar. Derek has a first class degree in Pharmacology from the University of Edinburgh where he was the Brunton medallist and Keasbey Bursary holder. Derek’s PhD in molecular cardiology is from the University of Cambridge. Derek is the Chief or Primary Investigator of multiple large trials in Cardiovascular medicine. Derek developed one of the UKs first primary angioplasty programmes and one of the UKs largest cardiac CT programmes. He has been a council member of the PCCS since it’s refoundation.
Read More
Professor Kausik Ray FMedSci
Professor of Public Heath, Department of Public Health and Primary Care, Imperial College London and Honorary Consultant Cardiologist, Imperial College NHS Trust
Prof Ray is Immediate Past President of the European Atherosclerosis Society, Chair of the World Heart Federation Cholesterol Roadmap, Lead for CVD NIHR Academic research Collaboration, NIHR ARC National Lead for CVD and Director of ICTU-Global which is an academic ARO.
He received his medical education (MB ChB, 1991) at the University of Birmingham Medical School, his MD (2004) at the University of Sheffield, a postdoctoral fellowship at Harvard Medical School and finally an MPhil in epidemiology (2007) from the University of Cambridge. His research involves lipids, diabetes and population health serving as global lead for trials and registries. He has >178,000 citations and since 2018 has been recognised by Clarivate Analytics as among the top 0.1% of authors in global medicine. In 2023 he was inducted as a Fellow of the Academy of Medical Sciences, which is UK’s highest honour for clinician scientists.
Read More
Professor Terry McCormack
GP in Whitby, North Yorkshire, Professor of Primary Care Cardiovascular Medicine at Hull York Medical School (HYMS) and Immediate Past President of the British and Irish Hypertension Society
Terry McCormack is a GP in Whitby, North Yorkshire, Professor of Primary Care Cardiovascular Medicine at HYMS and Immediate Past President of the British and Irish Hypertension Society. He is a primary care researcher, particularly interested in hypertension, lipids and anticoagulation. In 2020 he was the winner of the HYMS Undergraduate Medicine Phase II and III Teacher of Excellence Award. Guideline work includes the NICE Hypertension, Perioperative Care and Venous Thromboembolism guideline committees and the AAGBI/BHS preoperative BP guideline. He is an editor of the British Journal of Cardiology and a Fellow of the European Society of Cardiology.
Read More
Abbreviations
AAGBI, Association of Anaesthetics of Great Britain and Ireland; ARC, Applied Research Collaborations; ARO, academic research organisation; BHS, British Hypertension Society; BP, blood pressure; CT, clinical trial; CV, cardiovascular; CVD, cardiovascular disease; GB, Great Britain; GP, General Practitioner; HYMS, Hull York Medical School; ICTU, Imperial Clinical Trials Unit; MB ChB, Bachelor of Medicine and Surgery; MD, Doctor of Medicine; NHS, National Health Service; NICE, National Institute for Health and Care Excellence; NIHR, National Institute of Health and Care Research; PhD, Doctor of Philosophy; PCCS, Primary Care Cardiovascular Society; R&D, research and development; UK, United Kingdom.
Job code: UK/BIL/11/24/0011|Date of preparation: February 2025